SB 374-FN (2022): relative to the SARS-CoV-2 vaccinations.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“SB 374-FN (2022): relative to the SARS-CoV-2 vaccinations.” Granite Record, https://graniterecord.org/bill/2022/sb374. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). SB 374-FN (2022): relative to the SARS-CoV-2 vaccinations. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2022/sb374
Chicago
Granite Record. “SB 374-FN (2022): relative to the SARS-CoV-2 vaccinations.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2022/sb374.
BibTeX
@misc{bill-2022-sb374, title = {SB 374-FN (2022): relative to the SARS-CoV-2 vaccinations.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2022/sb374}, note = {Accessed 24 Oct. 2026} }

SB 374-FN (2022)

relative to the SARS-CoV-2 vaccinations.

  • Status: Referred for interim study
  • Term: 2021-2022
  • Senate committee: Health and Human Services
  • Subject: Miscellaneous

The Story

It was introduced on January 5, 2022 and referred to the Senate Health and Human Services committee. The committee held a public hearing on February 9, 2022. The committee recommended that the Senate study it after the session ends. On March 17, 2022 the Senate adopted “Refer to Interim Study, RC 18Y-6N”.

Sponsors

Hearings and Sessions

  • February 9, 2022, 10:30 AM: hearing, Senate Health and Human Services, SH 100

Votes

  • March 17, 2022, Senate: Interim Study — yeas 18, nays 6, passed

The Docket

  • January 5, 2022: To Be Introduced 01/05/2022 and Referred to Health and Human Services
  • February 9, 2022: Hearing: 02/09/2022, Room 100, SH, 10:30 am
  • March 17, 2022: Committee Report: Referred to Interim Study, 03/17/2022
  • March 17, 2022: Refer to Interim Study, RC 18Y-6N, MA; 03/17/2022

From the General Court